Progressive ataxia associated with ocular apraxia type 1 (AOA1) with a presence of a novel mutation on the aprataxin gene.

Rana AQ, Khan OA, Akthar R.

Ann Indian Acad Neurol. 2013 Apr;16(2):269-71. doi: 10.4103/0972-2327.112495.

Friedreich ataxia.

Gibilisco P, Vogel AP.

BMJ. 2013 Dec 3;347:f7062. doi: 10.1136/bmj.f7062. No abstract available.

Cerebellar ataxia impairs modulation of arm stiffness during postural maintenance.

Gibo TL, Bastian AJ, Okamura AM.

J Neurophysiol. 2013 Oct;110(7):1611-20. doi: 10.1152/jn.00294.2013.

Spinocerebellar ataxia type 13 is an uncommon SCA subtype in the Chinese Han population.

Peng L, Wang C, Chen Z, Wang JL, Tang BS, Jiang H.

Int J Neurosci. 2013 Jul;123(7):450-3. doi: 10.3109/00207454.2013.763254.

Assessment of whole-brain white matter by DTI in autosomal recessive spastic ataxia of Charlevoix-Saguenay.

Oguz KK, Haliloglu G, Temucin C, Gocmen R, Has AC, Doerschner K, Dolgun A, Alikasifoglu M.

AJNR Am J Neuroradiol. 2013 Oct;34(10):1952-7. doi: 10.3174/ajnr.A3488.

Pemetrexed induces both intrinsic and extrinsic apoptosis through ataxia telangiectasia mutated/p53-dependent and -independent signaling pathways.

Yang TY, Chang GC, Chen KC, Hung HW, Hsu KH, Wu CH, Sheu GT, Hsu SL.

Mol Carcinog. 2013 Mar;52(3):183-94. doi: 10.1002/mc.21842.

Combination of BK channel opener and Kv4 channel inhibitor for treatment of cerebellar ataxia in mutant med mice.

Abbasi S, Abbasi A, Sarbaz Y.

J Neuropsychiatry Clin Neurosci. 2013 Fall;25(4):E41. doi: 10.1176/appi.neuropsych.12100251. No abstract available.

Experience in a short-term trial with 4-aminopyridine in cerebellar ataxia.

Giordano I, Bogdanow M, Jacobi H, Jahn K, Minnerop M, Schoels L, Synofzik M, Teufel J, Klockgether T.

J Neurol. 2013 Aug;260(8):2175-6. doi: 10.1007/s00415-013-7029-5. No abstract available.

[Diagnostics of ataxia-telangiectasia by the express-test found on the method of indirect immunofluorescence].

Kuranova ML, Ledashcheva TA, Tulush EK, Beliaev DL, Zherebtsov SV, Pleskach NM, Prokof'eva VV, Mikhel'son VM, Spivak IM.

Tsitologiia. 2013;55(8):560-5. Russian.

Novel maculopathy in patients with spinocerebellar ataxia type 1 autofluorescence findings and functional characteristics.

Vaclavik V, Borruat FX, Ambresin A, Munier FL.

JAMA Ophthalmol. 2013 Apr;131(4):536-8. doi: 10.1001/jamaophthalmol.2013.1127. No abstract available.

Exome analysis reveals a Japanese family with spinocerebellar ataxia, autosomal recessive 1.

Ichikawa Y, Ishiura H, Mitsui J, Takahashi Y, Kobayashi S, Takuma H, Kanazawa I, Doi K, Yoshimura J, Morishita S, Goto J, Tsuji S.

J Neurol Sci. 2013 Aug 15;331(1-2):158-60. doi: 10.1016/j.jns.2013.05.018.

Safety and efficacy of umbilical cord mesenchymal stem cell therapy in hereditary spinocerebellar ataxia.

Jin JL, Liu Z, Lu ZJ, Guan DN, Wang C, Chen ZB, Zhang J, Zhang WY, Wu JY, Xu Y.

Curr Neurovasc Res. 2013 Feb;10(1):11-20.

A multimodal evaluation of microstructural white matter damage in spinocerebellar ataxia type 3.

Guimarães RP, D'Abreu A, Yasuda CL, França MC Jr, Silva BH, Cappabianco FA, Bergo FP, Lopes-Cendes IT, Cendes F.

Mov Disord. 2013 Jul;28(8):1125-32. doi: 10.1002/mds.25451.

Marked improvement in opsoclonus and cerebellar ataxia after the surgical removal of a squamous cell carcinoma of the thymus: a case report.

Yamaguchi Y, Wada M, Tanji H, Kurokawa K, Kawanami T, Ohtake H, Kato T.

J Neurol Sci. 2013 Feb 15;325(1-2):156-9. doi: 10.1016/j.jns.2012.11.011.

Altered GABAergic system in the living brain of a patient with spinocerebellar ataxia type 8.

Terada T, Kono S, Konishi T, Miyajima H, Ouchi Y.

J Neurol. 2013 Dec;260(12):3164-6. doi: 10.1007/s00415-013-7167-9. No abstract available.